TW200608985A - Method and compositions useful for preventing and/or treating sensitive and/or dry skin - Google Patents

Method and compositions useful for preventing and/or treating sensitive and/or dry skin

Info

Publication number
TW200608985A
TW200608985A TW094120988A TW94120988A TW200608985A TW 200608985 A TW200608985 A TW 200608985A TW 094120988 A TW094120988 A TW 094120988A TW 94120988 A TW94120988 A TW 94120988A TW 200608985 A TW200608985 A TW 200608985A
Authority
TW
Taiwan
Prior art keywords
preventing
dry skin
compositions useful
microorganism
treating sensitive
Prior art date
Application number
TW094120988A
Other languages
English (en)
Inventor
Lionel Breton
Roland Jourdain
Audrey Gueniche
Isabelle Bureau-Franz
Stephanie Blum-Sperisen
Original Assignee
Oreal
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal, Nestec Sa filed Critical Oreal
Publication of TW200608985A publication Critical patent/TW200608985A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
TW094120988A 2004-06-23 2005-06-23 Method and compositions useful for preventing and/or treating sensitive and/or dry skin TW200608985A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0451317A FR2872047B1 (fr) 2004-06-23 2004-06-23 Composition pour peaux sensibles associant cation mineral et probiotique(s)

Publications (1)

Publication Number Publication Date
TW200608985A true TW200608985A (en) 2006-03-16

Family

ID=34942654

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094120988A TW200608985A (en) 2004-06-23 2005-06-23 Method and compositions useful for preventing and/or treating sensitive and/or dry skin

Country Status (10)

Country Link
EP (1) EP1609463B1 (zh)
CN (1) CN1712022B (zh)
AR (1) AR049829A1 (zh)
AT (1) ATE509615T1 (zh)
BR (1) BRPI0502346B1 (zh)
CA (1) CA2510308C (zh)
ES (1) ES2366441T3 (zh)
FR (1) FR2872047B1 (zh)
TW (1) TW200608985A (zh)
ZA (1) ZA200700602B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI731209B (zh) * 2018-01-09 2021-06-21 柯順議 益生菌組合物及其用途

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005291098B2 (en) * 2004-10-04 2011-11-24 L'oreal Cosmetic and/or dermatological composition for sensitive skins
EP1731137A1 (fr) * 2005-06-08 2006-12-13 Nestec S.A. Composition cosmétique ou dermatologique pour peaux sèches et/ou sensibles
EP1642570A1 (fr) * 2004-10-04 2006-04-05 L'oreal Composition cosmétique et/ou dermatologique pour peaux sensibles
US20060269508A1 (en) 2005-03-29 2006-11-30 Trejo Amy V Means for regulating the cosmetic appearance and/or health of human keratinous tissue
EP2308566B1 (en) * 2005-04-08 2017-07-05 The Procter and Gamble Company Use of orally administered probiotic bifidobacteria for human beauty benefits
FR2915388B1 (fr) * 2007-04-27 2010-12-24 Oreal Film hydrosoluble cosmetique
BRPI0816214B8 (pt) * 2007-09-04 2017-12-26 Oreal uso cosmético, composição cosmética e/ou dermatológica, e, métodos para o tratamento cosmético da pele, para o tratamento cosmético de sinais cutâneos de envelhecimento e/ou fotoenvelhecimento e para o tratamento cosmético para prevenir e/ou tratar substâncias queratinosas secas
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
FR2920307B1 (fr) * 2007-09-04 2010-06-04 Oreal Utilisation cosmetique de microorganismes.
FR2920300B1 (fr) * 2007-09-04 2012-12-28 Oreal Utilisation d'une association hesperidine et microorganisme pour agir sur la fonction barriere de la peau.
FR2920301B1 (fr) * 2007-09-04 2009-12-04 Oreal Utilisation d'une association hesperidine et microorganisme pour le traitement de la secheresse des matieres keratiniques.
FR2920304B1 (fr) 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
WO2009107380A1 (ja) * 2008-02-29 2009-09-03 明治乳業株式会社 抗アレルギー剤
FR2938437B1 (fr) * 2008-11-19 2020-03-27 Société des Produits Nestlé S.A. Utilisation cosmetique de microorganisme pour le traitement des peaux grasses
FR2937547B1 (fr) 2008-10-28 2012-11-09 Oreal Utilisation d'un lysat de microorganisme pour le traitement des peaux grasses
FR2940908B1 (fr) 2009-01-12 2012-08-24 Oreal Association cosmetique d'un microorganisme et d'un derive phytosphingosine
FR2942719B1 (fr) * 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
FR2953407B1 (fr) * 2009-12-08 2013-06-14 Oreal Microorganismes probiotiques a titre d'actif contre les alterations du microrelief
FR2953408B1 (fr) * 2009-12-08 2013-02-08 Oreal Microorganismes probiotiques a titre d'actif pour l'eclat du teint de la peau
FR2957788B1 (fr) * 2010-03-24 2012-07-13 Oreal Procede cosmetique topique utilisant un microorganisme probiotique vivant
FR2959128B1 (fr) 2010-04-23 2012-07-13 Oreal Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement des odeurs corporelles
MY197622A (en) 2010-12-31 2023-06-28 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
SG191394A1 (en) 2010-12-31 2013-08-30 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
MY182335A (en) 2011-07-22 2021-01-19 Abbott Lab Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
US10639319B2 (en) 2011-08-29 2020-05-05 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
GB201206599D0 (en) * 2012-04-13 2012-05-30 Univ Manchester Probiotic bacteria
FR3055799B1 (fr) * 2016-09-15 2020-06-19 Basf Beauty Care Solutions France Sas Nouvelle utilisation cosmetique et/ou nutraceutique ou dermatologique d'un extrait de levure
CN112754988B (zh) * 2021-03-22 2022-06-28 中南大学湘雅二医院 一种降低皮肤致敏性的益生菌护肤品及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2647342B1 (fr) * 1989-05-23 1994-05-27 Sanofi Sa Composition cosmetique s'opposant au vieillissement de la peau
US5256649A (en) * 1989-05-23 1993-10-26 Elf Sanofi Cosmetic composition against aging of the skin
EP0737471A3 (fr) * 1995-04-10 2000-12-06 L'oreal Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue
FR2733151B1 (fr) * 1995-04-20 1997-05-23 Seppic Sa Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
EP0931543B1 (de) * 1997-12-19 2002-03-20 MERCK PATENT GmbH Mehrschichttablette enthaltend probiotische Mikroorganismen wie z.B. Lactobacilli oder Bifidobakterien
SE523771C2 (sv) * 1999-05-21 2004-05-18 Probi Ab Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller
GB9920578D0 (en) * 1999-08-31 1999-11-03 Nestle Sa Composition for maintenance of bone or dental health or treatment of bone or dental disorders
ATE397868T1 (de) * 1999-09-07 2008-07-15 Nestle Sa Verfahren zur verbesserung der haut und des pelzes von haustieren
EP1110555A1 (fr) * 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Agent anti-adhesion de la flore pathogene de la peau
ATE350010T1 (de) * 2001-02-23 2007-01-15 Richter Chem Lab Zusammensetzung zur topischen anwendung
BR0307839A (pt) * 2002-02-21 2004-12-07 Nestle Sa Composição fotoprotetora para a pele que pode ser administrada por via oral
ITMI20020399A1 (it) * 2002-02-28 2003-08-28 Ct Sperimentale Del Latte S P Composizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
RU2228184C2 (ru) * 2002-06-28 2004-05-10 Закрытое акционерное общество "Партнер" Комплексный препарат
KR20050094403A (ko) * 2002-12-13 2005-09-27 로레알 경구 투여로 피부의 피지 기능을 자극하기 위한 조성물제조에서의 카페인 제거 커피 원두 추출물의 용도
FR2848448B1 (fr) * 2002-12-13 2007-04-06 Oreal Utilisation d'un extrait de grains de cafe decafeine dans la preparation d'une composition destinee a stimuler la fonction sebacee de la peau par administration orale
FR2851889B1 (fr) * 2003-03-06 2007-05-04 Larena Sa Produit destine a la restauration de la tolerance aux antigenes alimentaires et bacteriens, et composition dietetique ou alimentaire contenant un tel produit

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI731209B (zh) * 2018-01-09 2021-06-21 柯順議 益生菌組合物及其用途

Also Published As

Publication number Publication date
BRPI0502346A (pt) 2006-04-18
EP1609463B1 (fr) 2011-05-18
CA2510308A1 (fr) 2005-12-23
CN1712022B (zh) 2012-02-15
EP1609463A1 (fr) 2005-12-28
FR2872047A1 (fr) 2005-12-30
ZA200700602B (en) 2008-07-30
CN1712022A (zh) 2005-12-28
CA2510308C (fr) 2012-02-21
BRPI0502346B1 (pt) 2015-10-06
AR049829A1 (es) 2006-09-06
ES2366441T3 (es) 2011-10-20
FR2872047B1 (fr) 2007-06-15
ATE509615T1 (de) 2011-06-15

Similar Documents

Publication Publication Date Title
TW200608985A (en) Method and compositions useful for preventing and/or treating sensitive and/or dry skin
TW200728285A (en) Diacylindazole derivatives as inhibitors of lipases and phospholipases
WO2008042231A3 (en) Compositions and methods for evaluating and treating heart failure
BRPI0516437A (pt) utilização de uma quantidade eficaz de pelo menos um microorganismo, processo de tratamento cosmético, composição cosmética e/ou dermatológica e composição para absorção oral
MY140514A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
MEP27408A (en) Use of gpr119 receptor agonists for increasing bone mass and for treating osteoporosis, and combination therapy relating thereto
WO2008153655A3 (en) Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic fhv-1 infections, and preventing or treating conjunctivitis
BRPI0717219A2 (pt) "composição imunogênica, método para tratar ou prevenir doença, e, uso de uma composição imunogênica."
EP2023926A4 (en) PYRIDONECARBOXAMIDE DERIVATIVES USEFUL FOR TREATING HYPERPROLIFERATIVE AND ANGIOGENESIS RELATED DISORDERS
MXPA06014510A (es) Composiciones y metodos para tratar trastornos inflamatorios.
NO20092639L (no) 4-fenyl-6-(2,2,2-trifluor-1-fenyletoksy)pynmidinbaserte forbindelser og anvendelser derav
MX2008003721A (es) Estructuras fibrosas con locion.
TW200722421A (en) Azole derivatives as inhibitors of lipases and phospholipases
TW200738263A (en) ANG2 and VEGF inhibitor combinations
DE602006015665D1 (de) Probiotische enterokokken für eine verbesserte immunität
NO20054369L (no) Anvendelse av en IBAT-inhibitor for behandling og profylakse av forstoppelse
ECSP11010975A (es) Método de uso de una cepa de bacillus subtilis para mejorar la salud de animales
RS51185B (sr) Kompozicije za vaginalnu primenu
TW200730513A (en) Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
WO2007081878A8 (en) Indoleamine 2,3-dioxygenase pathways in the generation of regulatory t cells
NO20092073L (no) Modulatorer av C3A-reseptor, og fremgangsmater for anvendelse derav
BRPI0718469A2 (pt) Uso de um antagonista de interleucina 1 (il-1), método para tratar, inibir, ou melhorar pseudogota, uso de um ou mais agentes terapêuticos, e, produto.
BRPI0620291B8 (pt) método e uso de 4,4'-diaminodifenil sulfona para produzir cepas rugosas de bactérias e composição de modulador imune
WO2009009034A3 (en) Methods and compositions useful in the treatment of mucositis
MY146444A (en) Benzooxazol-2-one derivatives as inhibitors of lipases and phospholipases